A phase 2 trial of Biogen and…
A phase 2 trial of Biogen and Ionis Pharmaceuticals’ tau-targeting [...]
Regenxbio’s gene therapy for…
Regenxbio’s gene therapy for Duchenne muscular dystrophy has smashed the [...]
Aptose Biosciences has scrapped a…
Aptose Biosciences has scrapped a deal for a blood cancer [...]
After axing its lead obesity asset…
After axing its lead obesity asset last year, BioAge Labs [...]
Lexicon CEO Michael Exton told…
Lexicon CEO Michael Exton told Fierce how he set the [...]
Fosun Pharma has paid $60 million…
Fosun Pharma has paid $60 million for an option on [...]
Valneva is planning to shrink its…
Valneva is planning to shrink its headcount by up to [...]
Kyverna Therapeutics has…
Kyverna Therapeutics has officially started a rolling submission to the [...]
If any proof was needed that big…
If any proof was needed that big money is still [...]
Boehringer Ingelheim has put up…
Boehringer Ingelheim has put up 407.5 million euros in biobucks [...]